Biosimilars Congregation 2012 ?Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars? February 24th 2012, Hilton London Euston Hotel, London UK For more info on the event and for event brochure kindly visit ? http://virtueinsight.com/site/Pharma_Details.aspx?SC_ID=24 Key Themes Discussed at this Summit: ? Reviewing some of the challenges in clinical study design for biosimilar development arising from endpoint variability, changes in clinical practice, and evolution in understanding of the biology of the disease ? How should the pharma and generics industries approach the rapidly emerging and developing biosimilar market? The future of next generation Biosimilars ? How are policy makers shaping the contours of this new generic frontier, and what implications they have for current biologic drug development and patent protection? ? Identifying issues and solutions surrounding biosimiliars and clinical trials. ?